Clinical Efficacy of MOAP Regimen for Relapsed/Refractory cHL as a Rescue Therapy After DP Regimen

Inclusion Criteria

• •1. Subjects must have histological confirmation of relapsed or refractory Hodgkin lymphoma (HL).
• •2. 13 to 70 years of age.
• •3. ECOG performance of less than 2.
• •4. Life expectancy of at least 3 months.
• •5. Subjects with lymphoma must have at least one measureable lesion \>1 cm as defined by lymphoma response criteria.
• •6. Subjects must have received at least two prior chemotherapy regimen and four cycle of DP regimen, and must be off therapy for at least 4 weeks prior to Day 1. Subjects with autologous hematopoietic stem-cell transplantation are eligible which must be more than 3 months.
• •7. Subjects must have adequate marrow, live, renal and heart functions.